Organ Markets
Keyword(s):
The Us
◽
This chapter examines the arguments in favor of and opposed to a market for kidney grafts from living sources. Although the National Organ Transplant Act (NOTA) of 1984 made it illegal to buy or sell organs in the US, and the World Health Organization recommended a similar ban in 1991 (which was reaffirmed in 2010), there is some support for a kidney market in academic circles. While measures to make living donation financially neutral for living donors are ethical and widely popular, payments that serve as incentives or bribes are neither. The buying and selling of living organ grafts are not an ethical means to mitigate the shortage of organs for transplantation.